TNFα, tumour necrosis factor α

The effect of etanercept on anti-cyclic citrullinated peptide antibodies and rheumatoid factor in patients with rheumatoid arthritis
H A Chen, K C Lin, C H Chen, H T Liao, H P Wang, H N Chang, C Y Tsai, C T Chou

Annals of the Rheumatic Diseases Jan 2006, 65 (1) 35-39; DOI: 10.1136/ard.2005.038851
Clinical efficacy of infliximab plus methotrexate in DMARD naive and DMARD refractory rheumatoid arthritis is associated with decreased synovial expression of TNFα and IL18 but not CXCL12
M van Oosterhout, E W N Levarht, J K Sont, T W J Huizinga, R E M Toes, J M van Laar

Annals of the Rheumatic Diseases Apr 2005, 64 (4) 537-543; DOI: 10.1136/ard.2004.024927
Interleukin 10 promoter microsatellite polymorphisms are associated with response to long term treatment with etanercept in patients with rheumatoid arthritis
H Schotte, B Schlüter, S Drynda, P Willeke, N Tidow, G Assmann, W Domschke, J Kekow, M Gaubitz

Annals of the Rheumatic Diseases Apr 2005, 64 (4) 575-581; DOI: 10.1136/ard.2004.027672
Methotrexate ameliorates T cell dependent autoimmune arthritis and encephalomyelitis but not antibody induced or fibroblast induced arthritis
F Lange, E Bajtner, C Rintisch, K S Nandakumar, U Sack, R Holmdahl

Annals of the Rheumatic Diseases Apr 2005, 64 (4) 599-605; DOI: 10.1136/ard.2004.026120
Lack of efficacy of rituximab in Wegener’s granulomatosis with refractory granulomatous manifestations
P M Aries, B Hellmich, J Voswinkel, M Both, B Nölle, K Holl-Ulrich, P Lamprecht, W L Gross

Annals of the Rheumatic Diseases Jul 2006, 65 (7) 853-858; DOI: 10.1136/ard.2005.044420
TNFα polymorphisms and risk of psoriatic arthritis
P Rahman, F Siannis, C Butt, V Farewell, L Peddle, F Pellett, D Gladman

Annals of the Rheumatic Diseases Jul 2006, 65 (7) 919-923; DOI: 10.1136/ard.2005.039164
Infliximab leads to a rapid but transient improvement in endothelial function in patients with primary systemic vasculitis
K Raza, D M Carruthers, R Stevens, A D Filer, J N Townend, P A Bacon

Annals of the Rheumatic Diseases Jul 2006, 65 (7) 946-948; DOI: 10.1136/ard.2005.043638
Repeated infusions of infliximab, a chimeric anti-TNFα monoclonal antibody, in patients with active spondyloarthropathy: one year follow up
E Kruithof, F Van den Bosch, D Baeten, A Herssens, F De Keyser, H Mielants, E M Veys

Annals of the Rheumatic Diseases Mar 2002, 61 (3) 207-212; DOI: 10.1136/ard.61.3.207
Differential association of polymorphisms in the TNFα region with psoriatic arthritis but not psoriasis
T Höhler, S Grossmann, B Stradmann-Bellinghausen, W Kaluza, E Reuss, K de Vlam, E Veys, E Märker-Hermann

Annals of the Rheumatic Diseases Mar 2002, 61 (3) 213-218; DOI: 10.1136/ard.61.3.213
Soluble tumour necrosis factor receptor treatment does not affect raised transforming growth factor β levels in rheumatoid arthritis
S Drynda, C Kühne, J Kekow

Annals of the Rheumatic Diseases Mar 2002, 61 (3) 254-256; DOI: 10.1136/ard.61.3.254

Main menu

TNFα, tumour necrosis factor α

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

TNFα, tumour necrosis factor α

Pages